Structural insights into the interaction between prion protein and nucleic acid.

The infectious agent of transmissible spongiform encephalopathies (TSE) is believed to comprise, at least in part, the prion protein (PrP). Other molecules can modulate the conversion of the normal PrP(C) into the pathological conformer (PrP(Sc)), but the identity and mechanisms of action of the key physiological factors remain unclear. PrP can bind to nucleic acids with relatively high affinity. Here, we report small-angle X-ray scattering (SAXS) and nuclear magnetic resonance spectroscopy measurements of the tight complex of PrP with an 18 bp DNA sequence. This double-stranded DNA sequence (E2DBS) binds with nanomolar affinity to the full-length recombinant mouse PrP. The SAXS data show that formation of the rPrP-DNA complex leads to larger values of the maximum dimension and radius of gyration. In addition, the SAXS studies reveal that the globular domain of PrP participates importantly in the formation of the complex. The changes in NMR HSQC spectra were clustered in two major regions: one in the disordered portion of the PrP and the other in the globular domain. Although interaction is mediated mainly through the PrP globular domain, the unstructured region is also recruited to the complex. This visualization of the complex provides insight into how oligonucleotides bind to PrP and opens new avenues to the design of compounds against prion diseases.

[1]  G. J. Raymond,et al.  Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells , 1993, Journal of virology.

[2]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[3]  B. Chesebro,et al.  Sulfated glycans and elevated temperature stimulate PrPSc‐dependent cell‐free formation of protease‐resistant prion protein , 2001, The EMBO journal.

[4]  A. Aguzzi,et al.  Mammalian Prion Biology One Century of Evolving Concepts , 2004, Cell.

[5]  F. Heitz,et al.  Alternative prion structural changes revealed by high pressure. , 2003, Biochemistry.

[6]  Nicholas M. Luscombe,et al.  Amino acid?base interactions: a three-dimensional analysis of protein?DNA interactions at an atomic level , 2001, Nucleic Acids Res..

[7]  J. Collinge,et al.  Location and properties of metal-binding sites on the human prion protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Dmitri I. Svergun,et al.  Uniqueness of ab initio shape determination in small-angle scattering , 2003 .

[9]  H. Tolentino,et al.  The Small-Angle X-ray Scattering Beamline of the Brazilian Synchrotron Light Laboratory , 1997 .

[10]  D. Svergun,et al.  Mathematical methods in small-angle scattering data analysis , 1991 .

[11]  Chandra S Verma,et al.  Prion and water: tight and dynamical hydration sites have a key role in structural stability. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Gabus,et al.  The Prion Protein Has RNA Binding and Chaperoning Properties Characteristic of Nucleocapsid Protein NCp7 of HIV-1* , 2001, The Journal of Biological Chemistry.

[13]  Roland Winter,et al.  The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation. , 2005, Biophysical journal.

[14]  S. Supattapone,et al.  Protease-resistant Prion Protein Amplification Reconstituted with Partially Purified Substrates and Synthetic Polyanions* , 2005, Journal of Biological Chemistry.

[15]  Bruce A. Johnson,et al.  NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.

[16]  D. Svergun,et al.  Looking behind the beamstop: X-ray solution scattering studies of structure and conformational changes of biological macromolecules. , 2003, Methods in enzymology.

[17]  A. Mangé,et al.  Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin , 2004, Journal of Cell Science.

[18]  P. Nandi,et al.  DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid. , 2002, Journal of molecular biology.

[19]  F E Cohen,et al.  Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Caughey,et al.  The Role of Helix 1 Aspartates and Salt Bridges in the Stability and Conversion of Prion Protein* , 2003, The Journal of Biological Chemistry.

[21]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[22]  Jerson L. Silva,et al.  Positive Contribution of Hydration on DNA Binding by E2c Protein from Papillomavirus* , 2004, Journal of Biological Chemistry.

[23]  J. Hope,et al.  Characterization of 2′-Fluoro-RNA Aptamers That Bind Preferentially to Disease-associated Conformations of Prion Protein and Inhibit Conversion* , 2003, Journal of Biological Chemistry.

[24]  J. Esko,et al.  Cellular Heparan Sulfate Participates in the Metabolism of Prions* , 2003, Journal of Biological Chemistry.

[25]  Ping Wang,et al.  DNA Aptamers That Bind to PrPC and Not PrpSc Show Sequence and Structure Specificity , 2006, Experimental biology and medicine.

[26]  Y. Cordeiro,et al.  Modulation of Prion Protein Oligomerization, Aggregation, and β-sheet Conversion by 4,4′-Dianilino-1,1′-binaphthyl-5,5′-sulfonate (bis-ANS)* , 2004, Journal of Biological Chemistry.

[27]  B. Caughey,et al.  Potent Antiscrapie Activities of Degenerate Phosphorothioate Oligonucleotides , 2006, Antimicrobial Agents and Chemotherapy.

[28]  K. Fiebig,et al.  Antimalarial drug quinacrine binds to C-terminal helix of cellular prion protein. , 2003, Journal of medicinal chemistry.

[29]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Y. Cordeiro,et al.  Hydration and packing effects on prion folding and beta-sheet conversion. High pressure spectroscopy and pressure perturbation calorimetry studies. , 2004, The Journal of biological chemistry.

[31]  K. Wüthrich,et al.  Prion protein interaction with the C-terminal SH3 domain of Grb2 studied using NMR and optical spectroscopy. , 2004, Biochemistry.

[32]  K. Lee,et al.  Internalization of mammalian fluorescent cellular prion protein and N‐terminal deletion mutants in living cells , 2001, Journal of neurochemistry.

[33]  W. James,et al.  Structural Determinants of Conformationally Selective, Prion-binding Aptamers*[boxs] , 2004, Journal of Biological Chemistry.

[34]  P. Gambetti,et al.  From Microbes to Prions The Final Proof of the Prion Hypothesis , 2005, Cell.

[35]  Shu G. Chen,et al.  Antibody to DNA detects scrapie but not normal prion protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Permanne,et al.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.

[37]  S. Supattapone,et al.  RNA molecules stimulate prion protein conversion , 2003, Nature.

[38]  P. Lansbury,et al.  Cell-free formation of protease-resistant prion protein , 1994, Nature.

[39]  D I Svergun,et al.  Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. , 1999, Biophysical journal.